Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 35,467 | 33,173 | 36,019 | 34,887 | 30,610 |
| Cost of Goods | 19,274 | 19,018 | 19,253 | 19,523 | 16,857 |
| Gross Profit | 16,193 | 14,155 | 16,766 | 15,364 | 13,753 |
| Operating Expenses | 84,436 | 91,696 | 81,695 | 90,363 | 52,183 |
| Operating Income | -67,969 | -77,523 | -64,676 | -74,476 | -37,573 |
| Interest Expense | 3,681 | 3,697 | 3,479 | 3,673 | 3,589 |
| Other Income | 256 | -279 | 1 | -133 | 161 |
| Pre-tax Income | -71,394 | -81,499 | -68,154 | -78,282 | -41,001 |
| Income Tax | N/A | N/A | 1,175 | -94,824 | N/A |
| Net Income Continuous | -71,394 | -81,499 | -69,329 | 16,542 | -41,001 |
| Net Income | $-71,394 | $-81,499 | $-69,329 | $16,542 | $-41,001 |
| EPS Basic Total Ops | -0.32 | -0.37 | -0.31 | 0.08 | -0.21 |
| EPS Basic Continuous Ops | -0.32 | -0.37 | -0.31 | 0.08 | -0.21 |
| EPS Diluted Total Ops | -0.32 | -0.37 | -0.31 | 0.08 | -0.21 |
| EPS Diluted Continuous Ops | -0.32 | -0.37 | -0.31 | 0.08 | -0.21 |
| EBITDA(a) | $-63,157 | $-72,414 | $-60,068 | $-70,285 | $-33,811 |